Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model

Hanna Shevalye, Roman Stavniichuk, Weizheng Xu, Jie Zhang, Sergey Lupachyk, Yury Maksimchyk, Viktor R. Drel, Elizabeth Z. Floyd, Barbara Slusher, Irina G. Obrosova

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science